(3R,4S)-1-benzyl-N,4-di-methylpiperidin-3-amine dihydrochloride
Tofacitinib Impurity 33 is listed by Simson Pharma as a impurity standards for laboratory research, analytical development and quality-control workflows.
Suitability is method- and purpose-specific. Before use, verify the product name, catalogue number, chemical identifiers, storage requirements and the information reported in the current product or batch documentation. Your laboratory remains responsible for method qualification or validation.
Buy 16372-08-0 Purchase 16372-08-0 Order 16372-08-0 Enquire 16372-08-0 16372-08-0 price 16372-08-0 supplier 16372-08-0 manufacturer 16372-08-0 exporter Tofacitinib Impurity 33 for method validation Tofacitinib Impurity 33 reference standard Tofacitinib Impurity 33 for ANDA filing Tofacitinib Impurity 33 for forced degradation studies Tofacitinib Impurity 33 identification standard Tofacitinib Impurity 33 for DMF filing Tofacitinib Impurity 33 HPLC standard Tofacitinib Impurity 33 supplier Tofacitinib Impurity 33 manufacturer Tofacitinib Impurity 33 distributor
